Wednesday, June 10, 2026

pharma

Amersham Sorin.S.r.l

Amersham Sorin.S.r.l patent portfolio β€” 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
0
Drugs
0
Patents
2
Intelligence Β· Patents

Amersham Sorin.S.r.l patents

2 pharmaceutical patents indexed for Amersham Sorin.S.r.l. 0 expire within 24 months.

Amersham Sorin.S.r.l has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

Patent portfolio

  1. EP 1028755

    VERFAHREN ZUR REDUKTION VON OXYGENIERTEN RHENIUM ODER TECHNETIUM VERBINDUNGEN

    Expires Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  2. AT E190067

    PEPTIDE MODIFIZIERT DURCH EINE PHOSPHIN GRUPPE ZUR MARKIERUNG MIT 99MTC UND 186-188RE ODER PARAMAGNETISCHE AGENTIEN

    Expires Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Amersham Sorin.S.r.l have?

2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Amersham Sorin.S.r.l patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.